Tags |
|
|
Links |
|
|
Advice Pool - Accelerating Active Adjustments in Material Memory Configurations
Material Memory is a very positive technology for the future and i
According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
t is already used in many industries. Unfortunately not all materi
; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.
Examples of combination products may in
Examples of combination products may in
ls, which are used in material memory or manufactured memory can r
lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.
turn to shape or shape shift fast enough for many of the applicati
here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
ns that they will be used for in the future.
There are new techno
There are new techno
d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.
Combination pro
Combination pro
ogies we can use to better assist our material memory needs such a
ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
using carbon nanotubes, which can conduct electricity and new Las
easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
er technologies, which can superheat materials for material memory
nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
purposes. Using light and lasers and energy or electrical impulses
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
with carbon nanotube materials or any other state-of-art materials
ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
which are similar to this.
We can use accelerating active adjust
We can use accelerating active adjust
ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.
Following aspects would a
Following aspects would a
ents with technology and techniques of customized materials and la
dd to the challenges in developing combination products:
Which markets to tap where the combination products can do fairly well?
Which combination prod
Which markets to tap where the combination products can do fairly well?
Which combination prod
er controls to more rapidly engage and stimulate material memory m
cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
terials. We need to be thinking here and be sure to be thinking ho
tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
w we can best utilize all these technologies not as separate techn
t?
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
logies but together and consider a merging of NanoTech, Optics, La
ping new procedures for reviewing their safety, efficacy and quality.
Professional from academic institutions, pharmaceutical industries, health care indust
Professional from academic institutions, pharmaceutical industries, health care indust
ers and Material Memory strategies, as alone they are absolutely p
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
enomenal, but together they break the boundaries of all present pe
.
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
iod known science and set us off in a path which will take mankind
elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.
Companies that provide selfless information through particip
Companies that provide selfless information through particip
into the future; and well, it is about time. Consider this in 2006
tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.advicepool.org.ua/article/220142/advicepool-Accelerating-Active-Adjustments-in-Material-Memory-Configurations.html">Accelerating Active Adjustments in Material Memory Configurations</a>
BB link (for phorums):
[url=http://www.advicepool.org.ua/article/220142/advicepool-Accelerating-Active-Adjustments-in-Material-Memory-Configurations.html]Accelerating Active Adjustments in Material Memory Configurations[/url]
Related Articles:
Butterfly Marketing and the Matrix: Keanu Reeves or My Guru?
Commercial Property Management Public Relations
Get Them Talking: Become the Freelance Writer Editors Love
Bookmark it:
|